Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0102
Research tool
Ouabain
Senolytic / Cardiac glycoside
Preclinical senescent-cell killing candidate
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Cardiac glycoside
- Primary mechanism
- Na+/K+-ATPase inhibition
- Primary market use
- Senolytic research
Pharmacology
- Molecular weight (Da)
- 584.65
- Oral bioavailability
- Poor oral; mainly parenteral/research
- Half-life
- ~20 h reported; variable
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical
- Clinical status
- Research tool
- Value-for-money score
- 1 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Narrow therapeutic index; not a practical value compound